(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) dropped by a staggering 26.52% in 10 sessions from €11.84 to €8.70 at 01:38 EST on Monday, after five sequential sessions in a row of losses. CAC 40 is sliding 1.43% to €6,925.40, following the last session’s downward trend.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABL Diagnostics’s stock is considered to be overbought (>=80).
More news about ABL Diagnostics (ABLD.PA).
